Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3437095 | 1.00 | TK1 (0.65) | TK1POLB | |
| SCHEMBL538835 | 1.00 | TK1 (0.65) | TK1POLB | |
| SCHEMBL3437098 | 1.00 | TK1 (0.65) | TK1POLB | |
| SCHEMBL25521507 | 1.00 | TK1 (0.65) | TK1POLB | |
| SCHEMBL655193 | 0.92 | TK1 (0.67) | TK1POLB | |
| SCHEMBL19224119 | 0.89 | TK1 (0.69) | TK1POLB | |
| SCHEMBL14063727 | 0.89 | TK1 (0.69) | TK1POLB | |
| Doxribtimine SCHEMBL10382149 | 0.89 | TK1 (0.73) | TK1 | |
| SCHEMBL12352406 | 0.89 | TK1 (0.69) | TK1POLB | |
| Doxribtimine SCHEMBL21078835 | 0.89 | TK1 (0.73) | TK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160125-A1 | Compositions and methods for nonenzymatic ligation of oligonucleotides and detection of genetic polymorphisms | UNIVERSITY OF ROCHESTER (US) | 2006-07-20 | — | — | US | claimed |
| EP-2677039-B1 | Detection of nucleic acid targets using chemically reactive oligonucleotide probes | DXTERITY DIAGNOSTICS (US) | 2022-08-17 | — | — | EP | disclosed |
| US-10829803-B2 | Detection of nucleic acid targets using chemically reactive oligonucleotide probes | DXTERITY DIAGNOSTICS INCORPORATED (US) | 2020-11-10 | — | — | US | disclosed |
| US-20190106739-A1 | CHEMICAL LIGATION DEPENDENT PROBE AMPLIFICATION (CLPA) | DXTERITY DIAGNOSTICS INCORPORATED | 2019-04-11 | — | — | US | disclosed |
| US-10066257-B2 | Methods and compositions for detecting target nucleic acids | DXTERITY DIAGNOSTICS INCORPORATED (US) | 2018-09-04 | — | — | US | disclosed |
| WO-2018143893-A1 | IDOXURIDINE AND ITS ANALOGS AS NEUROPROTECTANS FOR THE TREATMENT OF PARKINSONISM | SVENNINGSSON PER (SE) | 2018-08-09 | — | — | WO | disclosed |
| US-9976177-B2 | Chemical ligation dependent probe amplification (CLPA) | DXTERITY DIAGNOSTICS INCORPORATED (US) | 2018-05-22 | — | — | US | disclosed |
| US-20180030520-A1 | METHODS AND COMPOSITIONS FOR DETECTING TARGET NUCLEIC ACIDS | DXTERITY DIAGNOSTICS INCORPORATED | 2018-02-01 | — | — | US | disclosed |
| US-9745616-B2 | Methods and compositions for detecting target nucleic acids | DXTERITY DIAGNOSTICS INCORPORATED (US) | 2017-08-29 | — | — | US | disclosed |
| US-9696303-B2 | Assay device | RevoluGen Limited (GB) | 2017-07-04 | — | — | US | disclosed |
| EP-0767668-A4 | POLYNUCLEOSIDE CHAIN HAVING MULTIPLE NUCLEOSIDES, THE NUCLEOSIDES COUPLED BY GUANIDYL LINKAGES | UNIV CALIFORNIA (US) | 1998-04-08 | — | — | EP | disclosed |
| US-5677439-A | PREVENTION GENE EXPRESSION | SANOFI (FR) | 1997-10-14 | — | — | US | disclosed |
| WO-1997035869-A1 | DINUCLEOTIDE AND OLIGONUCLEOTIDE ANALOGUES | NOVARTIS AG (CH) | 1997-10-02 | — | — | WO | disclosed |
| EP-0767668-A1 | POLYNUCLEOSIDE CHAIN HAVING MULTIPLE NUCLEOSIDES, THE NUCLEOSIDES COUPLED BY GUANIDYL LINKAGES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-04-16 | — | — | EP | disclosed |
| WO-1996000575-A1 | POLYNUCLEOSIDE CHAIN HAVING MULTIPLE NUCLEOSIDES, THE NUCLEOSIDES COUPLED BY GUANIDYL LINKAGES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-01-11 | — | — | WO | disclosed |
| EP-0541722-B1 | COMPOUNDS AND METHODS FOR INHIBITING GENE EXPRESSION | STERLING WINTHROP INC (US) | 1995-12-20 | — | — | EP | disclosed |
| US-5449664-A | Nucleosides | SYNTEX (U.S.A.) INC. (US) | 1995-09-12 | — | — | US | disclosed |
| EP-0541722-A1 | COMPOUNDS AND METHODS FOR INHIBITING GENE EXPRESSION. | STERLING WINTHROP INC (US) | 1993-05-19 | — | — | EP | disclosed |
| WO-1992002534-A2 | COMPOUNDS AND METHODS FOR INHIBITING GENE EXPRESSION | STERLING DRUG, INC. (US) | 1992-02-20 | — | — | WO | disclosed |
| EP-0371366-A1 | Antiviral agents | SYNTEX (U.S.A.) INC. (US) | 1990-06-06 | — | — | EP | disclosed |